SEC Filings - Achieve Life Sciences

HOME
ABOUT ACHIEVE
PRODUCTS
- Cytisinicline
NEWS
INVESTORS
CONTACT

HOME
ABOUT ACHIEVE
- About Achieve
- Senior Management
PRODUCTS
- Cytisinicline
NEWS
INVESTORS
CONTACT

SEC Filings

Home / SEC Filings

Home ivps4 2017-06-16T21:39:52+00:00

Investors Home
Corporate Governance
News Releases
Financial Information
SEC Filings
Events and Webcasts
Investor Contacts
Investor Alerts

NASDAQ: ACHV NASDAQ: OGXI

NASDAQ: ACHV NASDAQ: OGXI

Year

ViewAll Filings

Form	Description	Date	Format

NASDAQ: ACHV NASDAQ: OGXI

1dy

1mo

6mo

1yr

5yr

Stock Info

NASDAQ: ACHV NASDAQ: OGXI

Achieve Life Sciences US Headquarters

22722 29th Dr SE, Suite 100
Bothell, WA 98021
Phone: (425) 686-1500

Email: info@achievelifesciences.com

Vancouver – Principal Executive Office

1040 W Georgia Street, Suite 1030
Vancouver, BC V6E 4H1

Email: info@achievelifesciences.com

About Achieve

About Achieve
Senior Management
Board of Directors
Cytisinicline
Contact

For Investors

Investors
News
Corporate Governance
Financial Information
SEC Filings
Investor Alerts

Recent News

Investor Alerts

Apr 22, 2021

Achieve Life Sciences, Inc. to Host Virtual Non-Deal Roadshow on Tuesday, April 27, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, April 22, 2021 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

© Copyright 2016 - | Achieve Life Sciences, Inc. All Rights Reserved | Privacy Policy | Disclaimer | Contact Us